DNA Methylation Activates TP73 Expression in Hepatocellular Carcinoma and Gastrointestinal Cancer
Open Access
- 18 December 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-10
Abstract
The complexity of TP73 expression and its functionality, as well as the role of TP73 in tumorigenesis, unlike its cousin TP53, which is an established tumor suppressor, have remained elusive to date. In this study, we isolated two stem cell lines (HepCY & HepCO) from normal young and old human liver tissues. We determined TP73 expression in HepCY and HepCO, hepatocellular cancer (HCC) cell lines (HepG2, SNU398, SNU449 and SNU475), gastrointestinal cancer (GI) cell lines (Caco2 and HCT116) and normal skin fibroblasts cell line (HS27). Immunohistochemical analyses of TP73 expression was also performed in non-cancerous and adjacent cancerous liver tissues of HCC patients. The results show that TP73 expression is exclusive to the cancer cell lines and not the adjacent normal liver tissues. Moreover, methylation-specific PCR and bisulfite sequencing studies revealed that TP73 promoter is activated only in cancer cell lines by DNA methylation. Furthermore, ChIP assay results demonstrated that a chromosomal networking protein (CTCF) and tumor protein p53 (TP53) bind to TP73 promoter and regulate TP73 expression. Our observations demonstrate that a positive correlation in tumorigenesis exists between TP73 expression and DNA methylation in promoter regions of TP73. These findings may prove significant for the development of future diagnostic and therapeutic applications.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (5U01CA185188-01A1)
This publication has 38 references indexed in Scilit:
- TP73 is a credible biomarker for predicting clinical progression and prognosis in cervical cancer patientsBioscience Reports, 2019
- TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast CancerJNCI: Journal of the National Cancer Institute, 2019
- Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axisBiochemical and Biophysical Research Communications, 2018
- Stem cell fate in cancer growth, progression and therapy resistanceNature Reviews Cancer, 2018
- Gene promoter and exon DNA methylation changes in colon cancer development – mRNA expression and tumor mutation alterationsBMC Cancer, 2018
- Epigenetic Determinants of CancerCold Spring Harbor Perspectives in Biology, 2016
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- CTCF: Master Weaver of the GenomeCell, 2009
- Linking DNA methylation and histone modification: patterns and paradigmsNature Reviews Genetics, 2009
- The p53 Family Member Genes Are Involved in the Notch Signal PathwayJournal of Biological Chemistry, 2002